header2.png

DIGITAL THERAPEUTICS
FOR CHRONIC PAIN AND NEUROLOGICAL CONDITIONS

Combining neuroscience and immersive technologies

CognifiSense is an innovator of digital therapeutics for the treatment of neurological conditions. 

 

Our therapies target the maladaptive neuroplastic changes in the brain caused by these neurological conditions, changes which drugs and devices are often unable to address.  Our virtual reality platform combines deep neuroscience and proprietary immersive technology to create corrective neuroplastic changes in the brain.

Group 14.png

Prescription digital therapeutics for chronic pain

VRNT.png

Our initial product, Virtual Reality Neuropsychological Therapy (VRNT) is a patented technology for treating chronic pain.

FDA.png

VRNT was one of eight winners of the 2018 FDA Innovation Challenge, giving it a status similar to a breakthrough medical device.  It was the first VR pain therapeutic to be so recognized by the FDA.